Suggestions
Sarah McGill
VP and Head of Global Access Strategy, Global Access
Professional Background
Sarah McGill is a distinguished leader in the pharmaceutical industry, renowned for her extensive expertise in global access strategy, pricing, and distribution within one of the world's leading biotechnology companies, Genentech. Currently serving as the Vice President and Head of Global Access Strategy at Genentech, Sarah has dedicated a significant portion of her career to improving access to innovative therapies for patients. Her strategic insights and leadership have played a pivotal role in shaping Genentech's approach to making essential medicines more accessible to healthcare providers and patients.
Sarah's journey at Genentech has been marked by a series of progressive roles that highlight her versatile capabilities and deep understanding of the healthcare landscape. She has formerly held the position of Senior Director for Corporate and Federal Accounts, where she was instrumental in developing strategies to navigate complex contracting and access challenges. Prior to this, Sarah served as the Marketing Director focused on Skin Cancer, where her innovative marketing strategies contributed to raising awareness and enhancing treatment access for patients afflicted by this condition.
Her initial foray into the realm of pricing and distribution was as the Director of Pricing, Contracting, and Distribution at Genentech, followed by the role of Associate Director for Distribution Strategy. Throughout her tenure, Sarah demonstrated exceptional leadership as the Group Manager of Distribution Strategy, where she managed operations to optimize distribution pathways and ensure timely delivery of products.
Sarah's foundational experience includes roles as a Senior Product Manager for the marketing of Xolair—a monoclonal antibody used in the treatment of asthma and chronic hives—as well as a Senior Forecasting Manager. Her early career also encompasses impactful marketing initiatives at BioScale, further solidifying her expertise in strategy and market positioning.
Education and Achievements
Sarah McGill's impressive educational background fortified her journey to becoming a prominent figure in the biotechnology landscape. She holds a Master of Business Administration (M.B.A.) from the prestigious Massachusetts Institute of Technology (MIT) Sloan School of Management, where she honed her skills in business strategy, leadership, and innovation.
In addition to her MBA, she has a Master of Science in Civil and Environmental Engineering from MIT, providing her a unique perspective on how engineering principles can be applied to solve complex problems in healthcare and biopharmaceutical environments. This blend of technical and business expertise positions her well to address the multifaceted challenges within the healthcare sector.
Prior to her graduate education, Sarah earned a Bachelor of Science degree in Industrial Engineering & Management Sciences from Northwestern University. This foundational training in industrial engineering has equipped her with analytical and optimization skills crucial for facilitating effective decision-making processes in the pharmaceutical industry.
Achievements
Throughout her illustrious career at Genentech, Sarah McGill has made significant contributions that showcase her strategic acumen and commitment to patient access. Her leadership in Global Access Strategy has resulted in innovative approaches to enhancing patient access to Genentech’s valuable therapies. Sarah's efforts extend beyond mere strategy formulation; she embodies the principles of collaboration and partnership among various stakeholders, including healthcare providers, payer organizations, and policy-makers, to create a comprehensive and accessible healthcare environment.
As a seasoned professional, Sarah's work has not only influenced Genentech’s market positioning but has also contributed to the broader dialogue on healthcare access and equity. Her dedication to patients and healthcare transformation continues to resonate within the industry, as she advocates for policies that enhance access to care and improve patient outcomes.
In summary, Sarah McGill’s extensive experience, impressive educational milestones, and commitment to healthcare innovation position her as a thought leader and driving force in the fields of access strategy and biopharma marketing. She exemplifies a deep-seated passion for making a tangible difference in the lives of patients through her work, paving the way for future advancements in accessible healthcare.
